Washington (AP) — A Committee of U.S. Health Advisors said Friday that Johnson & Johnson’s single-shot COVID-19 vaccine booster should be approved and provided at least two months after immunization. ..
J & J is asking the Food and Drug Administration for booster flexibility, claiming that additional doses will add significant protection two months after the first vaccination, but waiting up to six months will work. There is a possibility.
The FDA’s advisory board unanimously voted that boosters should be provided without a firm time. Advisors say that those who have been vaccinated with J & J appear to be less protected than those who have received the Pfizer or Moderna double vaccination option, and most people receive that single dose months ago. He said there was growing concern that he had received it.
The FDA is not bound by voting, but its final decision may help expand the country’s booster campaign.
The government states that all three US vaccines continue to provide strong protection against hospitalization and death from COVID-19, and giving the first injection to unvaccinated individuals is a priority. However, there is a growing movement to increase protection against “breakthrough” infections and highly contagious delta variants of the coronavirus.
Pfizer’s booster vaccine was launched last month for people at high risk for COVID-19, and the FDA Advisory Board recommends the same approach to Moderna recipients.
FDA Panel Approves Booster Shots for Johnson & Johnson COVID-19 Vaccine
Source link FDA Panel Approves Booster Shots for Johnson & Johnson COVID-19 Vaccine
The post FDA Panel Approves Booster Shots for Johnson & Johnson COVID-19 Vaccine appeared first on Illinois News Today.
No comments:
Post a Comment